The CTF Board of Directors has approved a new and bold strategic plan to bolster our mission to END NF. With a robust emphasis on NF research funding and the building of essential networks, and a firm foundation of NF awareness, education, and community, we move forward with an unwavering focus to lead and accelerate the innovation that will help NF patients – of all ages (kids and adults), and of all types of neurofibromatosis or schwannomatosis – to live better lives.
Read this summary document to learn more.
This NF Awareness Month, tune in for a special Make NF Research Visible webinar to learn about our innovative and ambitious plans to:
– Develop More NF Drugs
– Accelerate NF Treatments
– Strengthen NF Clinical Trials
– Empower the NF Community
Panelists include
– Annette Bakker, President
– Gabriel Groisman, Board Chair
– Liz Rodbell, Board Vice-Chair
– RB Harrison, Board Secretary
May 8, 2023 | 1:00 PM ET
